Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-01-01 @ 5:49 AM
Study NCT ID:
NCT04906733
Status:
UNKNOWN
Last Update Posted:
2021-08-13
First Post:
2021-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
Sponsor:
D1 Medical Technology (Shanghai) Co., Ltd, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-27
First Submit QC Date:
None
Study First Post Date:
2021-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-11
Last Update Post Date:
2021-08-13
Last Update Post Date Type:
ACTUAL